Post-IPO Equity Biotechnology Companies

Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.

IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.

Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.

RenalytixAI is a developer of artificial intelligence-enabled clinical diagnostic solutions for kidney health.

Next Science pioneers innovative, proprietary technologies to address the problem of biofilm.

PepGen is empowering nucleic acid therapeutics to go the distance.

PharmaTher Holdings pecializes in the development and commercialization of ketamine-based medicines.

Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.

Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

TNF Pharmaceuticals is researching groundbreaking treatments to address serious and debilitating autoimmune and inflammatory illnesses.

Onconetix is a biotechnology company that focuses on research and development of universal flu vaccines.

Therapeutic Solutions International is a biotechnology company engaged in the development of products for females.

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.

Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders.

Point Biopharma focused on the development and commercialization of radioligand therapies for the treatment of cancer.

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.

Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

Aditxt Therapeutics is a biotechnology company that develops a novel nucleic acid-based technology.

BioVie specializes in the development of innovative solutions for the treatment of neurodegenerative and liver diseases.

Devonian is a late stage botanical pharmaceutical corporation